Beverly Moy (@beverlymoy) 's Twitter Profile
Beverly Moy

@beverlymoy

Medical Oncologist, Clinical Director of Breast Oncology at Mass General Hospital; Professor, Harvard Medical School. Views my own.

ID: 1463076127

calendar_today27-05-2013 20:19:42

500 Tweet

1,1K Followers

277 Following

Beverly Moy (@beverlymoy) 's Twitter Profile Photo

Goals of care conversations should happen early and throughout the disease trajectory. ⁦Mass General Cancer Center⁩ ⁦MGH Women in Oncology⁩ ⁦MGH Breast Oncology⁩ Dr. Jenn Shin takes us through how to respond, understand, respect, support, and explore in these conversations.

Goals of care conversations should happen early and throughout the disease trajectory. ⁦<a href="/MGHCancerCenter/">Mass General Cancer Center</a>⁩ ⁦<a href="/MGH_WiO/">MGH Women in Oncology</a>⁩ ⁦<a href="/MGHBreastOnc/">MGH Breast Oncology</a>⁩ Dr. Jenn Shin takes us through how to respond, understand, respect, support, and explore in these conversations.
Beverly Moy (@beverlymoy) 's Twitter Profile Photo

Kevin Kalinsky, MD, MS, FASCO⁩ presents postMONARCH, the first trial showing benefit of continuing CDK4/6 inhibition after progression on prior CDK. Congrats to investigators, including senior author ⁦Mass General Cancer Center⁩ ⁦MGH Breast Oncology⁩ Seth Wander #ASCO24

⁦<a href="/KalinskyKevin/">Kevin Kalinsky, MD, MS, FASCO</a>⁩ presents postMONARCH, the first trial showing benefit of continuing CDK4/6 inhibition after progression on prior CDK. Congrats to investigators, including senior author ⁦<a href="/MGHCancerCenter/">Mass General Cancer Center</a>⁩ ⁦<a href="/MGHBreastOnc/">MGH Breast Oncology</a>⁩ Seth Wander #ASCO24
Beverly Moy (@beverlymoy) 's Twitter Profile Photo

Triple combo of inavolisib plus palbo plus fulvestrant meaningfully improves PFS and more in first line met ER+ PIK3CA mutant breast cancer. This is a very promising treatment. Amazing work energetically presented by ⁦Mass General Cancer Center⁩ Dejan Juric and colleagues #ASCO24

Triple combo of inavolisib plus palbo plus fulvestrant meaningfully improves PFS and more in first line met ER+ PIK3CA mutant breast cancer. This is a very promising treatment. Amazing work energetically presented by ⁦<a href="/MGHCancerCenter/">Mass General Cancer Center</a>⁩ Dejan Juric and colleagues #ASCO24
Beverly Moy (@beverlymoy) 's Twitter Profile Photo

Amazing discussion with Lori Pierce and ⁦Dr. Rob Winn⁩ at #ASCO24 EDI breakfast. “We have to do what is possible.” How we respond to challenges is vital. Missing 3 giants: Worta McCaskill-Stevens, Bill Blackstock, and Edith Mitchell.

Amazing discussion with Lori Pierce and ⁦<a href="/DrRobWinn/">Dr. Rob Winn</a>⁩ at #ASCO24 EDI breakfast. “We have to do what is possible.” How we respond to challenges is vital. Missing 3 giants: Worta McCaskill-Stevens, Bill Blackstock, and Edith Mitchell.
Beverly Moy (@beverlymoy) 's Twitter Profile Photo

I’m honored and thrilled to chair the brilliant ⁦ASCO⁩ Evidence Based Medicine Committee charged to provide the highest quality clinical practice #ASCOGuidelines. An impressive group of volunteer experts and staff! Lotsa guidelines coming your way!

I’m honored and thrilled to chair the brilliant ⁦<a href="/ASCO/">ASCO</a>⁩ Evidence Based Medicine Committee charged to provide the highest quality clinical practice #ASCOGuidelines. An impressive group of volunteer experts and staff! Lotsa guidelines coming your way!
ASCO (@asco) 's Twitter Profile Photo

We’ve issued a rapid guideline update for the management of stage III #NSCLC. ➡️ brnw.ch/21wKCWv #lungcancer #lcsm

We’ve issued a rapid guideline update for the management of stage III #NSCLC. ➡️ brnw.ch/21wKCWv #lungcancer #lcsm
ASCO (@asco) 's Twitter Profile Photo

We’ve issued a rapid guideline update on systemic therapy for #sclc. These recommendations are considered provisional pending full text review of publication and confirmation of data. ➡️ brnw.ch/21wKD3i #lungcancer #lcsm

We’ve issued a rapid guideline update on systemic therapy for #sclc. These recommendations are considered provisional pending full text review of publication and confirmation of data. ➡️ brnw.ch/21wKD3i #lungcancer #lcsm
Matthew Gubens (@mattgubensmd) 's Twitter Profile Photo

Such warm hospitality from Indonesian oncologists! Representing #ASCOGuidelines @asco at their annual oncology meeting, ISMI HOTTI. Jakarta is the kota kolaborasi, or city of collaboration, indeed! Thanks Beverly Moy Christina Annunziata Nancy Baxter MD PhD for joining virtually! Thanks for having

Such warm hospitality from Indonesian oncologists! Representing #ASCOGuidelines @asco at their annual oncology meeting, ISMI HOTTI. Jakarta is the kota kolaborasi, or city of collaboration, indeed! Thanks <a href="/BeverlyMoy/">Beverly Moy</a> <a href="/CMAnnunziata/">Christina Annunziata</a> <a href="/enenbee/">Nancy Baxter MD PhD</a> for joining virtually! Thanks for having
Beverly Moy (@beverlymoy) 's Twitter Profile Photo

I am thrilled to support Mass General Cancer Center MGH Women in Oncology team! Please donate or join us on Sep 15th to see if the rumors that I am singing with Jeffrey peppercorn MD band "What She Said" are true. because.massgeneral.org/fundraiser/572…

Beverly Moy (@beverlymoy) 's Twitter Profile Photo

The US FDA has approved adjuvant ribociclib + AI for HR+ HER2- Stage II and III breast cancer pts. Let's put our heads together to better explore appropriate use, given pt financial burden, ~8% grade 3 transaminase rate, and other toxicity. Choice of CDK 4/6 inhibitor? Duration?

Matteo Lambertini, MD PhD (@matteolambe) 's Twitter Profile Photo

Just published in Journal of Clinical Oncology the updated ASCO guidelines on fertility preservation in people with #cancer: a must read for all colleagues involved in cancer care to increase awareness on #oncofertility issues OncoAlert Ann Partridge MD, MPH Oncofertility Link: ascopubs.org/doi/10.1200/JC…

Just published in <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> the updated <a href="/ASCO/">ASCO</a> guidelines on fertility preservation in people with #cancer: a must read for all colleagues involved in cancer care to increase awareness on #oncofertility issues
<a href="/OncoAlert/">OncoAlert</a> <a href="/AnnPartridgeMD/">Ann Partridge MD, MPH</a> <a href="/oncofertility/">Oncofertility</a>
Link:
ascopubs.org/doi/10.1200/JC…
Beverly Moy (@beverlymoy) 's Twitter Profile Photo

Proud to be on the ASCO MA #ASCOAdvocacySummit team for increased NIH funding, prior auth fix, and oncology drug shortage reform. ⁦Aparna Raj Parikh⁩ @drn_cancerpcp

Proud to be on the <a href="/ASCO/">ASCO</a> MA #ASCOAdvocacySummit team for increased NIH funding, prior auth fix, and oncology drug shortage reform. ⁦<a href="/aparna1024/">Aparna Raj Parikh</a>⁩ @drn_cancerpcp